| Theme | Obscure gastrointestinal bleeding (OGIB) | |
|---|---|---|
| Title | Obscure gastrointestinal bleeding in patients undergoing hemodialysis | |
| Publish Date | 2019/08 | |
| Author | Naoki Hosoe | Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine |
| Author | Yukie Hayashi | Division of Gastroenterology and Hepatology, Keio University School of Medicine |
| Author | Makoto Mutaguchi | Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine |
| Author | Kaoru Takabayashi | Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine |
| Author | Makoto Naganuma | Division of Gastroenterology and Hepatology, Keio University School of Medicine |
| Author | Haruhiko Ogata | Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine |
| Author | Takanori Kanai | Division of Gastroenterology and Hepatology, Keio University School of Medicine |
| [ Summary ] | Gastrointestinal bleeding is a major complication in patients undergoing dialysis and is attributed to platelet dysfunction secondary to uremia and intermittent anticoagulant use in those undergoing hemodialysis. Patients undergoing hemodialysis and/or those with chronic kidney disease show a high incidence of small bowel lesions and can be a risk factor for recurrent bleeding in cases of obscure gastrointestinal bleeding (OGIB). Additionally, it is necessary to carefully monitor patients because bleeding may be prolonged or intense, and even minute lesions may cause OGIB. | |